Home › Research › Disparities
The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals
Deborah A. Levine, Jeremy B. Sussman, Rodney A. Hayward, Andrzej T. Gałecki, Rachael T. Whitney, Emily M. Briceño, Alden L. Gross, Bruno Giordani et al.. Journal of Alzheimer s Disease, 2025-01-01
Topic: Risk, prevention and care in population studies
Plain-language summary
average annual dementia incidence in White, but not Black, adults (1% versus 0%), due to hypertensive individuals' greater survival, and reduce annual ASCVD events more in Black than White adults (13% versus 5%). Under a SPRINT-based strategy, individuals with hypertension gained more years lived without dementia, ASCVD, myocardial infarction, or stroke and more years lived in optimal brain health. A SPRINT-based strategy did not attenuate individual-level race disparities in outcomes, except stroke. Due to longer life expectancy, a SPRINT-based strategy did not substantially reduce lifetime dementia risk in either group. The JNC-8-based strategy had similar but smaller effects as the SPRINT-based strategy. Our results suggest that tighter population-level BP control would not reduce population-level disparities in dementia between US Black and White adults.
What this study adds
Evidence grade: Low
A simulation found that tighter population-level blood pressure control would not reduce population-level disparities in dementia between US Black and White adults. It did not substantially reduce lifetime dementia risk in either group because people lived longer.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Levine, D. A., Sussman, J. B., Hayward, R. A., Gałecki, A. T., Whitney, R. T., Briceño, E. M., et al. (2025). The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals. Journal of Alzheimer s Disease. https://doi.org/10.1177/13872877241302506
Vancouver
Levine DA, Sussman JB, Hayward RA, Gałecki AT, Whitney RT, Briceño EM, et al. The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals. Journal of Alzheimer s Disease. 2025. doi:10.1177/13872877241302506. PMID: 39772767.
BibTeX
@article{levine2025-39772767,
author = {Levine, Deborah A. and Sussman, Jeremy B. and Hayward, Rodney A. and Gałecki, Andrzej T. and Whitney, Rachael T. and Briceño, Emily M. and Gross, Alden L. and Giordani, Bruno and others},
title = {{The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals}},
journal = {Journal of Alzheimer s Disease},
year = {2025},
doi = {10.1177/13872877241302506},
pmid = {39772767},
url = {https://doi.org/10.1177/13872877241302506}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- average annual dementia incidence in White, but not Black, adults (1% versus 0%), due to hypertensive individuals' greater survival, and reduce annual ASCVD events more in Black than White adults (13% versus 5%).
- Under a SPRINT-based strategy, individuals with hypertension gained more years lived without dementia, ASCVD, myocardial infarction, or stroke and more years lived in optimal brain health.
- A SPRINT-based strategy did not attenuate individual-level race disparities in outcomes, except stroke.
- Due to longer life expectancy, a SPRINT-based strategy did not substantially reduce lifetime dementia risk in either group.
- The JNC-8-based strategy had similar but smaller effects as the SPRINT-based strategy.
Why it matters
A simulation found that tighter population-level blood pressure control would not reduce population-level disparities in dementia between US Black and White adults. It did not substantially reduce lifetime dementia risk in either group because people lived longer.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Alzheimer s Disease) |
| Journal's citation record | 2 / 4 | Journal of Alzheimer s Disease: journal h-index 218 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author James Francis Burke: h-index 61 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Johns Hopkins University: institution h-index 2,306 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 12 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39772767) |
| Free to read | 2 / 2 | Free to read |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Disparities from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.